Stocks · Health care · Pharmaceutical Preparations

OCULAR THERAPEUTIX, INC

OCUL Clue Score42

United States Fiscal year ends December CIK 0001393434 Results filed 3 Aug 2026

Add to watchlist

What the insiders did Net buying

By person

28 insiders · 143 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Summer Road LLC entity

10% owner

$23.35M (34)

—

+$23.35M

14,210,262

6.47%

$103.59M

+50.8%

Pravin Dugel

See Remarks

—

$3.00M (11) scheduled

−$3.00M

3,270,332

1.49%

$23.84M

—

Amarpreet Sawhney

Chairman of the Board

$950.29K (6)

—

+$950.29K

1,245,424

0.5671%

$9.08M

+51.6%

Richard L Md Lindstrom

Director

$775.34K (3)

$143.00K (1)

+$632.34K

260,933

0.1188%

$1.90M

+499.0%

Peter Kaiser

Chief Development Officer

—

$397.68K (10) scheduled

−$397.68K

254,388

0.1158%

$1.85M

+114.4%

Donald Notman

Chief Operating Officer

$108.65K (3)

$455.10K (10)

−$346.45K

366,529

0.1669%

$2.67M

+1,930%

Nadia Waheed

Chief Medical Officer

—

$332.46K (4) scheduled

−$332.46K

300,079

0.1366%

$2.19M

—

Jeffrey S. Heier

Chief Scientific Officer

$145.35K (2)

$426.11K (10) scheduled

−$280.76K

307,457

0.1400%

$2.24M

+168.0%

Namrata Saroj

Chief Business Officer

—

$277.79K (1) scheduled

−$277.79K

254,620

0.1159%

$1.86M

+26.4%

Sanjay Nayak

Chief Strategy Officer

—

$261.55K (11) scheduled

−$261.55K

326,898

0.1488%

$2.38M

+226.9%

Antony C. Mattessich

President and CEO

$500.99K (6)

$269.63K (3)

+$231.36K

595,201

0.2710%

$4.34M

—

Todd Anderman

Chief Legal Officer

—

$224.73K (2) scheduled

−$224.73K

140,484

0.0640%

$1.02M

—

Daniel M Bollag

Sr. VP Reg. Affairs & Quality

$197.30K (2)

—

+$197.30K

42,100

0.0192%

$306.91K

—

Opaleye Management Inc. entity

Previously a 10% owner

$137.92K (3)

—

+$137.92K

5,122,500

2.33%

$37.34M

+0.7%

Kevin F. Hanley

Sr. VP Technical Operations

$111.00K (2)

—

+$111.00K

20,000

0.0091%

$145.80K

—

Rabia Gurses Ozden

Chief Medical Officer

—

$100.58K (4)

−$100.58K

153,054

0.0697%

$1.12M

+365.7%

Philip C. Strassburger

General Counsel

—

$89.32K (3)

−$89.32K

161,493

0.0735%

$1.18M

+3,399%

Christopher G White

Chief Business Officer

—

$78.92K (3)

−$78.92K

123,689

0.0563%

$901.69K

—

Michael H. Goldstein

President, Ophthalmology & CMO

$71.62K (2)

—

+$71.62K

313,335

0.1427%

$2.28M

+37.4%

Leslie J. Williams

Director

$19.80K (1)

—

+$19.80K

65,433

0.0298%

$477.01K

—

Bruce Peacock

Director

—

— (1)

$0.00

0

0.0000%

$0.00

—

Steve Lawrence Meyers

Chief Commercial Officer

—

—

—

217,628

0.0991%

$1.59M

+42.5%

David Wayne Robinson

Global CCO

—

—

—

136,000

0.0619%

$991.44K

—

Charles M Warden

Director

—

—

—

100,464

0.0457%

$732.38K

−95.5%

Jason Shand Robins

Chief Financial Officer

—

—

—

68,097

0.0310%

$496.43K

+29.3%

Adrienne L Graves

Director

—

—

—

64,000

0.0291%

$466.56K

—

Merilee Raines

Director

—

—

—

60,933

0.0277%

$444.20K

—

Seung Suh Hong

Director

—

—

—

60,933

0.0277%

$444.20K

—